Furthermore, there were no difference between healthy controls and Crohn’s disease patients in remission, implying that CYP downregulation is proportional to disease severity and that recovery resulted in a return to baseline metabolic activity (Sanaee et al., 2011). The gene discussed is PPIG; the disease is Crohn disease.